Proton therapy developer Ion Beam Applications (IBA) has received Japanese regulatory approval for its ProteusOne proton therapy system.
Clearance comes under the Japanese Pharmaceutical and Medical Device Act for the compact intensity-modulated proton therapy (IMPT) device, which is already cleared for use in the U.S. and Europe.
